Refractory Heart Failure clinical trials

Explore recruiting refractory heart failure clinical trials.

Recruiting refractory heart failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Heart Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EFFECT OF THE USE OF DAPAGLIFLOZIN IN DIURESIS, NATRIURIESIS AND IN ULTRAFILTRATION AND PERITONEAL ELIMINATION OF SODIUM, IN PATIENTS WITH REFRACTORY HEART FAILURE (DAPA-DP study)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Refractory Heart Failure trials by city

Refractory Heart Failure in Toronto Refractory Heart Failure in Vancouver Refractory Heart Failure in Montreal Refractory Heart Failure in Calgary Refractory Heart Failure in Edmonton Refractory Heart Failure in Ottawa Refractory Heart Failure in Winnipeg Refractory Heart Failure in Quebec City Refractory Heart Failure in Hamilton Refractory Heart Failure in Kitchener Refractory Heart Failure in London Refractory Heart Failure in Halifax Refractory Heart Failure in New York Refractory Heart Failure in Los Angeles Refractory Heart Failure in Chicago Refractory Heart Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease